Project description
The Czech Republic establishes the Pharma Centre of Excellence in Advanced Technology
Nucleic acids including DNA and RNA have shown exciting potential for the treatment of many diseases, not to mention their use in vaccines as demonstrated during the COVID-19 pandemic. Directed transport to specific tissues and cells remains a challenge. The Faculty of Pharmacy at Masaryk University in the Czech Republic is in an excellent position to tackle this challenge. The EU-funded ExcellPharmTech project will recruit a European Research Area Chair to establish the Pharma Centre of Excellence in Advanced Technology, intensifying research and development to enable the targeted delivery of nucleic acids to target cells and develop strategic partnerships for faster translation of the advanced drugs into clinics.
Objective
Masaryk University (MU) is the second-largest university in the Czech Republic located in Brno. Thanks to the ESIF funding, MU was able to acquire top research infrastructure attracting talented researchers who gradually built the position of the MU as the top regional hub for education, research, and innovation.
To further exploit this potential, the management structures and processes of the university must thoroughly implement the European Research Area (ERA) Priorities. As an outstanding researcher/innovator can have a decisive and positive impact on the culture and performance of any institution, MU will recruit a world-class research manager as an ERA Chair for its newly-established Faculty of Pharmacy.
The Faculty of Pharmacy (MUNI Pharm) is, besides others, focused on the development of advanced drug formulations and molecular biology techniques. The ERA Chair will intensify the research and development of advanced drug formulation and nanotechnologies to open new opportunities to intensify MUNI Pharm research capacities in the field of pharmacy and develop strategic partnerships with the application sphere and public sector for faster translation of the advanced drugs into clinics.
The recruitment of leading scientist will enforce the connection of the MUNI Pharm to research structures of MU, and the ERA Chair will make a bridge in the formation of unique education and research facility at one place titled MUNI BioPharma Hub, supported from National Recovery Plan (part of RRF – Recovery and Resilience Facility, NextGeneration EU).
To solve the targeted delivery and transportation of nucleic acids into target cell environment, the MUNI Pharm will establish an interdisciplinary center of excellence (Pharma Center of Excellence in Advanced Technology) with prof. David Oupický as its leader. The creation of an international ERA Chair team will ensure a successful establishment of the center combining excellent research, high level education and top innovations.
Fields of science
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- social scienceseconomics and businessbusiness and managementinnovation management
- engineering and technologynanotechnology
- medical and health sciencesbasic medicinepharmacology and pharmacy
- natural sciencesbiological sciencesmolecular biology
Keywords
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
601 77 Brno
Czechia